Axsome Therapeutics Inc (NASDAQ: AXSM) is 20.16% higher on its value in year-to-date trading and has touched a low of $64.11 and a high of $139.13 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AXSM stock was last observed hovering at around $97.55 in the last trading session, with the day’s gains setting it 4.12%.
Currently trading at $101.67, the stock is -12.52% and -15.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.49 million and changing 4.22% at the moment leaves the stock 4.66% off its SMA200. AXSM registered 40.99% gain for a year compared to 6-month gain of 20.81%. The firm has a 50-day simple moving average (SMA 50) of $119.8462 and a 200-day simple moving average (SMA200) of $97.1427.
The stock witnessed a -14.92% loss in the last 1 month and extending the period to 3 months gives it a 21.35%, and is -7.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.32% over the week and 4.99% over the month.
Axsome Therapeutics Inc (AXSM) has around 683 employees, a market worth around $4.96B and $385.69M in sales. Fwd P/E is 44.91. Profit margin for the company is -74.47%. Distance from 52-week low is 58.59% and -26.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-116.42%).
with sales reaching $121.15M over the same period.The EPS is expected to grow by 47.22% this year, but quarterly earnings will post 60.23% year-over-year. Quarterly sales are estimated to grow 61.54% in year-over-year returns.
397.0 institutions hold shares in Axsome Therapeutics Inc (AXSM), with institutional investors hold 92.80% of the company’s shares. The shares outstanding are 48.67M, and float is at 40.08M with Short Float at 12.24%. Institutions hold 77.40% of the Float.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 4.63 million shares valued at $373.06 million. The investor’s holdings represent 9.7415 of the AXSM Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 3.74 million shares valued at $301.23 million to account for 7.8956 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.3 million shares representing 6.9367 and valued at over $265.65 million, while FAIRMOUNT FUNDS MANAGEMENT LLC holds 4.9609 of the shares totaling 2.36 million with a market value of $189.99 million.
Axsome Therapeutics Inc (AXSM) Insider Activity
The most recent transaction is an insider sale by Pizzie Nick, the company’s Chief Financial Officer. SEC filings show that Pizzie Nick sold 12,000 shares of the company’s common stock on Feb 13 ’25 at a price of $129.86 per share for a total of $1.56 million. Following the sale, the insider now owns 42187.0 shares.
Axsome Therapeutics Inc disclosed in a document filed with the SEC on Feb 14 ’25 that Pizzie Nick (Chief Financial Officer) sold a total of 3,000 shares of the company’s common stock. The trade occurred on Feb 14 ’25 and was made at $131.07 per share for $0.39 million. Following the transaction, the insider now directly holds 42187.0 shares of the AXSM stock.
Still, SEC filings show that on Feb 14 ’25, Pizzie Nick (Officer) Proposed Sale 3,000 shares at an average price of $131.07 for $0.39 million. The insider now directly holds shares of Axsome Therapeutics Inc (AXSM).
